Erin Stephens, PhD
VP of Tissue Engineering and Antibody Discovery
Dr. Stephens joined Prellis Biologics in September 2019, with the mission of advancing the biological applications of 3D printed vascular tissue structures towards transplantable therapies for human patients. During her thesis, Dr. Stephens focused on pathway engineering in mammalian cells to hijack natural machinery and allow therapeutic access to the undruggable proteome. Between her defense and joining Prellis, Dr. Stephens worked as a biomolecular engineering specialist, consulting on the revamping of product development processes and quality systems to facilitate both innovation and first-to-market strategies for biotech clients. Dr. Stephens is an avid board gamer, volleyball enthusiast, fantasy novelist, and a loving gardener.